By analyzing the knowledge of primary liver cancer in Chinese medicine books and modern medicine, we will explore the current status of the knowledge and treatment methods of primary liver cancer in Chinese and Western medicine, apply the unique features of Chinese medicine and Western medicine, make the correct decision of combining Chinese and Western medicine in an integrated and holistic way, and use the treatment methods and treatment methods suitable for this patient in this period, instead of limiting to a single Chinese medicine therapy or Western medicine therapy, in order to promote the recovery of the patient, and provide new ideas for the primary This will promote the recovery of patients and provide new ideas for the clinical treatment of primary liver cancer.

Zhang Ju, Xie Xinke. Research Progress in the Treatment of Liver Cancer with Integrated Traditional Chinese and Western Medicine. Frontiers in Medical Science Research (2024), Vol. 6, Issue 9: 44-48. https://doi.org/10.25236/FMSR.2024.060907.

[1] Long Jiang, Gao Chang. Expert consensus on combined Chinese and western medicine interventional diagnosis and treatment of primary hepatocellular carcinoma (Trial first edition) [J]. Journal of Clinical Hepatobiliary Diseases, 2022, 38(01):70-77. 

[2] Qian Liyuan, Li Changfei, Luo Yunjing, Meng Songdong. Research progress of alpha-fetoprotein in the diagnosis and treatment of hepatocellular carcinoma [J]. Journal of Bioengineering, 2021, 37(09): 3042-3060. 

[3] Kulik L, El-Serag B H. Epidemiology and Management of Hepatocellular Carcinoma[J].  Gastroenterology,2018,156(2):477-491.e1.

[4] DING Xiaoyi, WANG Zheng, SHI Jie, et al. Expert consensus on multidisciplinary comprehensive treatment of hepatocellular carcinoma In China [J]. Journal of Clinical Hepatobiliary Diseases, 2021, 37 (02): 278-285.

[5] RIMCH, KIMCY, YANGDS, et al. External beam radiation therapy to hepatocellular carcinoma involving inferior vena cava and/or right atrium: a Meta - analysis and systemic review[J]. Radiother Oncol, 2018, 129(1): 123 - 129 

[6] KIMJ, JUNGY. Radiation - induced liver disease: current understanding and future perspectives[J]. Exp Mol Med, 2017, 49(7)e359.

[7] Guo Weiwei, Liu Li, Wu Dehua. DC-CIK cellular immunotherapy combined with TACE for primary hepatocellular carcinoma[J]. Journal of Southern Medical University, 2014, 34(05):674-678.

[8] Cai Xiaojun. Study on long-term and systemic anti-tumor effects of laser immunotherapy on H22 hepatocellular carcinoma in mice[D]. Southern Medical University, 2014. 

[9] Zhu Hongbin, Wang Dongxu. Research progress related to molecular targeted therapy for hepatocellular carcinoma[J]. Journal of Graduate Medicine, 2019, 32(07):744-749.

[10] Ye Lihong, Cheng Haibo, Zhang Yonghong, Zhou Zhongying. Discussion on the etiology of primary hepatocellular carcinoma in Chinese medicine[J]. Lishizhen Medicine and Materia Medica Research, 2010, 21(10): 2627-2628.

[11] Mao Yining, Wu Zheli. Research progress of diaphragm-under-diaphragm and blood stasis-expelling soup in the treatment of primary hepatocellular carcinoma[J]. Beijing Traditional Chinese Medicine, 2022, 41(01):103-106.

[12] Feng Kunliang, Chen Qinglian, Xie Chunfeng, Zhong Chong. Strengthening the spleen and removing blood stasis formula affects migration, invasion and epithelial mesenchymal transformation of hepatocellular carcinoma cells via exosomes in vitro[J]. New Chinese Medicines and Clinical Pharmacology, 2021, 32(12):1745-1751. 

[13] Xu F, Zeng YL, Li Juan, Cai S, Tang X, Wang Z, Xiao LH, Li SH. Progress of research on the mechanism of action of traditional Chinese medicine compound against hepatocellular carcinoma[J]. Chinese Journal of Experimental Formulas, 2019, 25(24):196-204. 

[14] Wu Qinxiang, Li Haozhao, Qiao Zeqiang, Jia Tingyin. Inhibitory effect of Chaihu saponin D on proliferation of human hepatocellular carcinoma HepG2 cell line and hepatocellular carcinoma formation in nude mice[J]. Chinese Journal of Immunology, 2018, 34(11):1664-1668.

[15] Zhang Chao, Huang Xiyan, Li Xiang, Li Qingrui, Zhang Dong, Li Wenrui, Zhang Yi, Zhang Shuofeng. In vivo antitumor effects and mechanism of Chonglou Saponin VII on hepatocellular carcinoma[J]. New Chinese Medicines and Clinical Pharmacology, 2022, 33(01):7-13.